FDA Sprinkles Some Rain On the PCSK9 Inhibitor Parade

Mar 7 2014, 5:58pm CST | by

In the last few years the PCSK9 inhibitors have been one of the few bright lights in an otherwise dismal field of new cardiovascular drugs. Now the FDA is raising questions that could dramatically slow down the progress of these new cholesterol-lowering drugs.

Last month Regeneron disclosed that it had been “advised by the FDA that it has become aware of neurocognitive adverse events in the PCSK9 inhibitor class. The FDA requested that Regeneron and its partner, Sanofi, “make an assessment of potential neurocognitive adverse events across the global development program” of their PCSK9 inhibitor, alirocumab. Regeneron and Sanofi said they were “not aware of any neurocognitive adverse event signal relating to alirocumab” but warned that “if this or another adverse event signal is detected, the further development of alirocumab may be delayed or fail, or its commercial value diminished.”

No one remarked on the statement last month when it was buried in the Regeneron annual report. But when the same statement was discovered today in Sanofi’s annual report, a Twitter storm ensued, and the companies’ stocks, as well as Amgen’s (which is also developing a PCSK9 inhibitor) took significant hits.

Reporters and analysts asked around but found no obvious source for the FDA’s concerns. Regeneron, Sanofi, Amgen, and Pfizer all denied finding any signal for neurocognitive adverse events in their data.

Short of the remote possibility that neurocognitive adverse events could scuttle the entire class of drugs, a more likely problem is that these concerns could result in serious delays in the approval of these drugs, which many thought were on a smooth path to approval. Most ominously, the companies said that the FDA asked “about the feasibility of incorporating neurocognitive testing into at least a subset of patients” in clinical trials. The conventional wisdom has been that the PCSK9 inhibitors will be able to gain approval before the completion of outcome studies. The concern now is that the FDA will insist that these studies be completed before the drugs can be approved.

Source: Forbes Business

 
 

Don't miss ...

 

<a href="/latest_stories/all/all/30" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

blog comments powered by Disqus

Latest stories

India leads South Asia in 'doing business' easier: World Bank
Washington, Oct 29 (IANS) A new World Bank Group report finds that India set the pace for regulatory reform in South Asia in 2013/14 India with 20 - the region's largest reforms during the period.
 
 
China's yuan strengthens
Beijing, Oct 29 (IANS) The value of the Chinese currency renminbi, or the yuan, strengthened by 16 basis points to 6.1405 against the US dollar in its central parity Wednesday, authorities said.
 
 
US nurse beat Ebola released from hospital
Washington, Oct 29 (IANS/EFE) Amber Vinson, one of the two Dallas nurses who cared for an Ebola-infected Liberian man and then infected with the virus themselves, was released from Emory University Hospital in Atlanta Tuesday after a 10-day stay.
 
 
Chinese peacekeepers to help build Ebola quarantine center
United Nation, Oct. Oct 29 (IANS) The Chinese contingent of the UN Mission in Liberia (UNMIL) will help build an Ebola Quarantine and Control Center in the capital city of Monrovia, a UN spokesperson said here Tuesday.
 
 
 

Latest from the Network

US unmanned spacecraft explodes shortly after launch
Washington, Oct 29 (IANS) An unmanned spaceship operated by a private US firm exploded just minutes after its launch Tuesday, media reported. The rocket blew up over the launch complex at Wallops Island, Virginia,...
Read more on Politics Balla
 
A$AP Rocky and Chanel Iman split
A$AP Rocky and Chanel Iman have reportedly ended their engagement. The 26-year-old rapper, who secretly proposed to the Victoria's Secret model in April after less than a year of dating, recently split from the 23-year-...
Read more on Celebrity Balla
 
Australian troops conduct G20 security training
Sydney, Oct 29 (IANS) Australian special forces troops have conducted G20 training exercises involving a mock hostage recovery operation in Brisbane Tuesday. Australian Defence Force spokesman for the G20, Maj. Gen....
Read more on Politics Balla
 
Nick Jonas angry over band split?
Los Angeles, Oct 29 (IANS) Pop star Nick Jonas is reportedly angry with his siblings over the breakup of their band - The Jonas Brothers. The trio disbanded in October last year after pulling out of a North American...
Read more on Celebrity Balla
 
Chinese peacekeepers to help build Ebola quarantine center
United Nation, Oct. Oct 29 (IANS) The Chinese contingent of the UN Mission in Liberia (UNMIL) will help build an Ebola Quarantine and Control Center in the capital city of Monrovia, a UN spokesperson said here Tuesday...
Read more on Business Balla
 
IS captures three gas wells in Syria
Damascus, Oct 29 (IANS) The Islamic State(IS) militants Tuesday captured three gas wells in Syria's central province of Homs, media reported. The IS captured the gas wells east of Palmyra in Homs after intense clashes...
Read more on Politics Balla
 
Jennifer Lawrence and Chris Martin's split wasn't dramatic
Jennifer Lawrence's split from Chris Martin reportedly ''wasn't dramatic.'' The 'Hunger Games' actress quietly decided to end her relationship with the Coldplay frontman a few weeks ago after four months of dating...
Read more on Celebrity Balla
 
Eddie Redmayne just wants to pay his mortgage
Eddie Redmayne says he is just trying to pay his mortgage. The 'Les Miserables' actor, who is set to marry antiques dealer Hannah Bagshawe in December, claims he doesn't consider himself ''a movie star'' and doesn't...
Read more on Celebrity Balla
 
Jane Lynch finalizes divorce
Jane Lynch's ex-wife Dr. Lara Embry received millions in their divorce. The 'Glee' star, whose split from clinical psychologist was finalized on Monday (10.27.14), following their separation in February 2012, reportedly...
Read more on Celebrity Balla
 
David McIntosh keen to marry Kelly Brook
London, Oct 29 (IANS) Following their recent reconciliation, actor David McIntosh says he wants to marry his on-off girlfriend Kelly Brook. The 28-year-old star is eager to wed the model in Mykonos, Greece, reports...
Read more on Celebrity Balla